미국에서 승인 후 Tidepool loop의 유럽 규제 경로
PMID: 37873612 ·
L, a, u, r, a, , D, o, w, n, e, y, ;, , S, h, a, n, e, , O, ', D, o, n, n, e, l, l, ;, , T, o, m, , M, e, l, v, i, n, ;, , M, u, i, r, e, a, n, n, , Q, u, i, g, l, e, y
광고
초록
The recent clearance by the United States Food and Drug Administration of Tidepool Loop sets an important precedent within the medical device landscape. For the first time, an automated insulin delivery mobile application-based on an algorithm initially designed and developed by users -has been recognised as safe and effective by a regulatory body. The aim of this paper is twofold: firstly, we map out the regulatory pathways and processes that were navigated by Tidepool, the non-profit behind Ti
광고
공식 출처
PubMed에서 보기 →데이터는 PubMed / NCBI에서 제공됩니다. 전문과 최신 정보는 반드시 공식 기록을 확인하세요.